1-HETEROCYCLYLALKYL-3-SULFON YLAZAINDOLE OR -AZAINDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS

Details for Australian Patent Application No. 2003254002 (hide)

Owner WYETH

Inventors Li, David Zenan; Lenicek, Steven Edward; Bernotas, Ronald Charles; Elokdah, Hassan Mahmoud

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2003254002

PCT Number PCT/US03/22506

PCT Pub. Number WO2004/009600

Priority 60/396,949 18.07.02 US

Filing date 17 July 2003

Wipo publication date 9 February 2004

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 031/454

A61P 025/00 Drugs for disorders of the nervous system

Event Publications

30 October 2003 Complete Application Filed

  Priority application(s): 60/396,949 18.07.02 US

18 March 2004 Application Open to Public Inspection

  Published as AU-A-2003254002

3 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003254003-PR/SET-DOMAIN CONTAINING NUCLEIC ACIDS, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE

2003254001-NOVEL HTNFSF13B PROTEIN VARIANTS